The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines

Carcinogenesis

Volumn 22, Issue 6, 2001, Pages 943-950

  Yueh, Mei Fei ^a   Nguyen, Nghia ^a   Famourzadeh, Maryam ^a   Strassburg, Christian P ^b   Oda, Yoshimitsu ^c   Guengerich, F Peter ^d   Tukey, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; AROMATIC AMINE; BETA GALACTOSIDASE; CYTOCHROME P450 1A2; FLUORENYLACETOHYDROXAMIC ACID; GLUCURONOSYLTRANSFERASE; HETEROCYCLIC AMINE; HYDROXYLAMINE; MUTAGENIC AGENT; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; BACTERIAL MEMBRANE; CANCER; CELL CULTURE; CONTROLLED STUDY; DETOXIFICATION; DIET; DNA DAMAGE; DNA MODIFICATION; DNA REPAIR; DOSE RESPONSE; ENVIRONMENTAL FACTOR; ENZYME SUBSTRATE; ESCHERICHIA COLI; GENOTOXICITY; GLUCURONIDATION; HUMAN; INCUBATION TIME; METABOLITE; MUTAGENIC ACTIVITY; NONHUMAN; OXIDATION; PREVENTION; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

EID: 0034992376     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.6.943     Document Type: Article

References (54)

1. Human UDP-glucuronosyltransferases: Metabolism, expression, and disease
2. Differential down regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer
3. Polymorphic gene expression and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine
4. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
5. Carcinogenic aromatic amine metabolism and DNA adduct detection in humans
6. Overview of carcinogenic heterocyclic amines
7. The genotoxicity of aromatic amines in primary hepatocytes isolated from C57BL/6 and DBA/2 mice
8. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo
9. Metabolic activation routes of arylamines and their genotoxic effects
10. The molecular biology of cytochrome P450s
11. Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites
12. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon
13. Metabolism of 2-acetylaminofluorene, benzo(a) pyrene and the activation of food derived heterocyclic amine mutagens by human cytochromes P450
14. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocylic amines
15. Interspecies differences in metabolism of heterocyclic aromatic amines by rat and human P450 1A2
16. Metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine by human cytochrome P4501A1, P4501A2 and P4501B1
17. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2
18. Enzymic and interindividual differences in the human metabolism of heterocyclic amines
19. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and humans
20. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans
21. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus
22. Differential expression of the UGT1A locus in human liver, biliary and gastric tissue. Identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue
23. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8
24. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium
25. 14C)2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine metabolites in humans
26. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo(4, 5-b)pyridine by human microsomal UDP-glucuronosyltransferases: Identification of specific UGT1A family isoforms involved
27. Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: Biological modeling of the ED01 study
28. 2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation
29. Metabolism of 2-amino-1-methyl-6-imidazo(4,5-b)pyridine (PhIP) by liver microsomes and isolated rabbit cytochrome P450 isozymes
30. Azido- and nitro-PhIP, relatives of the heterocyclic arylamine and food mutagen PhIP-mechanism of their mutagenicity in Salmonella
31. Mutagenesis of the N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine DNA adduct in mammalian cells. Sequence context effects
32. Evaluation of the new system (umuC-test) for the detection of environmental mutagens and carcinogens
33. SOS function tests for studies of chemical carcinogenesis using Salmonella typhimurium TA1535/pSK1002, NM2009 and NM3009
34. Quantification of mutagenic/carcinogenic heterocyclic amines, MeIQx, Trp-P-1, Trp-P-2 and PhIP, contributing highly to genotoxicity of river water
35. Genotoxic activity of 1-nitropyrene in water from the Yodo River, Japan
36. Metabolism of benzo(a)pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase
37. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds
38. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1
39. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs
40. Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes
41. Catalytic properties of polymorphic human cytochrome P450 1B1 variants
42. Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase
43. Development of high sensitive umu test system: Rapid detection of genotoxicity of promutagenic aromatic amines by Salmonella typhimurium strain NM2009 possessing high O-acetyltransferase activity
44. Use of a newly developed tester strain Salmonella typhimurium NM2009 for the study of metabolic activation of carcinogenic aromatic amines by rat liver microsomal cytochrome P-450 enzymes
45. Characterization of the UDP-Glucuronosyltransferase 1A Locus in Lagomorphs: Evidence for Duplication of the UGT1A6
46. Baculovirus-directed expression of rabbit UDP-glucuronosyltransferases in Spodoptera Frugiperda cells
47. 14C)glucuronic acid
48. Drug metabolism by Escherichia coli expressing human cytochromes P450
49. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli
50. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates
51. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes
52. UDP-glucuronosyltransferase activity in human liver and colon
53. Validation of the SOS/umu test using test results of 486 chemicals and comparison with the Ames test and carcinogenicity data
54. Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures